Arch Venture Management, LLC

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 9Value: $206.2MLatest: 2025Q1

ARCH Venture Management, LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 9 holdings worth $0.2 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "RAPP",
  null,
  null,
  "QTTB",
  "UBX",
  "GOSS",
  "ERAS",
  "VERV",
  "BEAM"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 9
Total Value: 206219148
Accession Number: 0001012975-25-000245
Form Type: 13F-HR
CIK: arch-venture-management
Manager Name: Arch-Venture-Management

Data Enrichment

78% identified

7 identified2 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

9 positions • $206.2M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Sort by:

Beam Therapeutics Inc.

BEAM|07373V105

Shares:4.5M

Value:$88.7M

% of Portfolio:43.0% ($88.7M/$206.2M)

578784100

Shares:4.1M

Value:$45.4M

% of Portfolio:22.0% ($45.4M/$206.2M)

Rapport Therapeutics, Inc.

RAPP|75383L102

Shares:3.7M

Value:$37.5M

% of Portfolio:18.2% ($37.5M/$206.2M)

Erasca, Inc.

ERAS|29479A108

Shares:11.1M

Value:$15.1M

% of Portfolio:7.3% ($15.1M/$206.2M)

Verve Therapeutics, Inc.

VERV|92539P101

Shares:2.0M

Value:$9.1M

% of Portfolio:4.4% ($9.1M/$206.2M)

Gossamer Bio, Inc.

GOSS|38341P102

Shares:8.1M

Value:$8.8M

% of Portfolio:4.3% ($8.8M/$206.2M)

Unity Biotechnology, Inc.

UBX|91381U200

Shares:1.0M

Value:$1.0M

% of Portfolio:0.5% ($1.0M/$206.2M)

Q32 Bio Inc.

QTTB|746964105

Shares:320.5K

Value:$532.0K

% of Portfolio:0.3% ($532.0K/$206.2M)

71902K303

Shares:22.1K

Value:$16.1K

% of Portfolio:0.0% ($16.1K/$206.2M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Beam Therapeutics Inc.(BEAMcusip07373V105)	4.5M	QoQ 0.00% (-0) YoY NEW(+4.5M)	All Managers (Combined)	$88.7M	43.0% ($88.7M/$206.2M)	QoQ -21.25% (-$23.9M) YoY NEW(+$88.7M)
(cusip578784100)✕	4.1M	QoQ NEW(+4.1M) YoY NEW(+4.1M)	All Managers (Combined)	$45.4M	22.0% ($45.4M/$206.2M)	QoQ NEW(+$45.4M) YoY NEW(+$45.4M)
Rapport Therapeutics, Inc.(RAPPcusip75383L102)	3.7M	QoQ 0.00% (-0) YoY NEW(+3.7M)	All Managers (Combined)	$37.5M	18.2% ($37.5M/$206.2M)	QoQ -43.23% (-$28.6M) YoY NEW(+$37.5M)
Erasca, Inc.(ERAScusip29479A108)	11.1M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$15.1M	7.3% ($15.1M/$206.2M)	QoQ -45.41% (-$12.6M) YoY -33.49% (-$7.6M)
Verve Therapeutics, Inc.(VERVcusip92539P101)	2.0M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$9.1M	4.4% ($9.1M/$206.2M)	QoQ -19.50% (-$2.2M) YoY -65.81% (-$17.6M)
Gossamer Bio, Inc.(GOSScusip38341P102)	8.1M	QoQ 0.00% (+0) YoY 0.00% (-0)	All Managers (Combined)	$8.8M	4.3% ($8.8M/$206.2M)	QoQ +20.49% (+$1.5M) YoY -7.62% (-$725.0K)
Unity Biotechnology, Inc.(UBXcusip91381U200)	1.0M	QoQ 0.00% (+0) YoY 0.00% (-0)	All Managers (Combined)	$1.0M	0.5% ($1.0M/$206.2M)	QoQ +6.51% (+$63.9K) YoY -36.58% (-$602.9K)
Q32 Bio Inc.(QTTBcusip746964105)	320.5K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$532.0K	0.3% ($532.0K/$206.2M)	QoQ -51.74% (-$570.5K) YoY -90.25% (-$4.9M)
(cusip71902K303)✕	22.1K	QoQ NEW(+22.1K) YoY NEW(+22.1K)	All Managers (Combined)	$16.1K	0.0% ($16.1K/$206.2M)	QoQ NEW(+$16.1K) YoY NEW(+$16.1K)